Liver Disease News and Research

RSS

The liver is one of the largest solid organs of the body. It is located in the upper right part of the abdomen. Most of the organ lies under cover of the rib cage.

Bile acid transporter inhibitors can prevent NASH in mice, study shows

Drugs that interfere with bile acid recycling can prevent several aspects of NASH (nonalcoholic steatohepatitis) in mice fed a high-fat diet, scientists from Emory University School of Medicine and Children's Healthcare of Atlanta have shown.

21 Sep 2016

New global health strategy aims to eliminate HCV as global public health threat by 2030

Chronic infection by the hepatitis C virus (HCV) proved fatal for over 700,000 people worldwide in 2013, mainly as a result of liver damage. Although information on the epidemiology of transmission and infection is sparse, recent estimates put the global prevalence of HCV infection at 130-150 million people.

21 Sep 2016

UofL investigators to explore liver disease in comprehensive fashion

Liver diseases are clinically important health problems and are generally underappreciated. The University of Louisville has brought together a critical mass of investigators to study liver diseases in a comprehensive fashion.

14 Sep 2016

Study reveals effectiveness of endoscopic suturing of colon perforations

As the number of people receiving colonoscopies has increased in recent years, polyp detection has improved and the number of endoscopic procedures to remove polyps has increased.

13 Sep 2016

Philips unveils innovative interventional oncology solution for liver cancer treatment at CIRSE 2016

Royal Philips today announced that it will unveil its latest innovation in interventional oncology at the 2016 Cardiovascular and Interventional Radiological Society of Europe annual meeting (CIRSE 2016), which will be held in Barcelona (Spain) from September 10 until 14.

13 Sep 2016

SLUCare cancer doctor offers advice to manage anxiety after cancer diagnosis

The first few days after a cancer diagnosis can feel overwhelming. At the very moment when you must make key decisions about your treatment and care, your brain may feel overloaded processing the distressing news you've just received.

13 Sep 2016

Novel Trojan Horse antibody strategy may target Ebola's Achilles' heel

In research published online today in Science, a team of scientists describe a new therapeutic strategy to target a hidden Achilles' heel shared by all known types of Ebola virus.

8 Sep 2016

University of Nebraska-Lincoln wins $11.3 million NIH grant to establish CIBC

The University of Nebraska-Lincoln has earned an $11.3 million grant from the National Institutes of Health to establish a research center focused on investigating cellular level miscommunications that contribute to complex diseases such as cancer, diabetes and chronic liver disease.

31 Aug 2016

Scientists generate functional tissue-engineered liver from adult stem and progenitor cells

A research team led by investigators at The Saban Research Institute of Children's Hospital Los Angeles has generated functional human and mouse tissue-engineered liver from adult stem and progenitor cells.

31 Aug 2016

Researchers find better way to purify liver cells made from induced pluripotent stem cells

A research team including developmental biologist Stephen A. Duncan, D. Phil., SmartState Chair of Regenerative Medicine at the Medical University of South Carolina, has found a better way to purify liver cells made from induced pluripotent stem cells (iPSCs).

30 Aug 2016

Researcher receives NIH grant to detect increasing Mtb activity in people with HIV

Tuberculosis (TB) is the leading cause of death worldwide among people infected with HIV.

29 Aug 2016

Engineered gut bacteria may one day help reduce negative health effects of obesity

A new therapy that involves engineered gut bacteria may one day help reduce the health problems that come with obesity. Incorporating the engineered bacteria into the guts of mice both kept them from gaining weight and protected them against some of the negative health effects of obesity.

28 Aug 2016

New oral anticoagulants offer same stroke prevention, but cause less intracranial bleeding than warfarin

The new oral anticoagulants provide the same stroke prevention as warfarin but cause less intracranial bleeding, reports an observational study in more than 43 000 patients presented at ESC Congress 2016 today by Dr Laila Staerk, a research fellow at Herlev and Gentofte University Hospital, Denmark.

28 Aug 2016

Can-Fite BioPharma reports financial results, provides update on drug development programs

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs being developed to treat inflammatory diseases, cancer and sexual dysfunction, today reported financial results for the six months ended June 30, 2016 and updates on its drug development programs.

27 Aug 2016

Liver Disease News and Research

Further Reading

Bile acid transporter inhibitors can prevent NASH in mice, study shows

New global health strategy aims to eliminate HCV as global public health threat by 2030

UofL investigators to explore liver disease in comprehensive fashion

Study reveals effectiveness of endoscopic suturing of colon perforations

Philips unveils innovative interventional oncology solution for liver cancer treatment at CIRSE 2016

SLUCare cancer doctor offers advice to manage anxiety after cancer diagnosis

Novel Trojan Horse antibody strategy may target Ebola's Achilles' heel

University of Nebraska-Lincoln wins $11.3 million NIH grant to establish CIBC

Scientists generate functional tissue-engineered liver from adult stem and progenitor cells

Researchers find better way to purify liver cells made from induced pluripotent stem cells

Researcher receives NIH grant to detect increasing Mtb activity in people with HIV

Engineered gut bacteria may one day help reduce negative health effects of obesity

New oral anticoagulants offer same stroke prevention, but cause less intracranial bleeding than warfarin

Can-Fite BioPharma reports financial results, provides update on drug development programs

Liver cancer time-bomb as up to 70% people with Hep C miss out on follow-up testing

Low selenium levels linked to liver cancer risk? An interview with Dr David Hughes

Hydrothermal DMR results show promise in treatment of type 2 diabetes

Researchers urge people with suspected hepatitis C to get tested to prevent risk of liver disease

Obstructive sleep apnea and hypoxia linked to progression of NAFLD in obese adolescents

RNA silencing technique developed by spinoff from UM-Madison effective in battling hepatitis B

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News